rs5878

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BA1BP4BS2_SupportingBP7

This summary comes from the ClinGen Evidence Repository: The variant is reported at a popmax FAF of 0.7651 and the highest MAF of 0.7792 (78%; 19440/24948 alleles with 7592 homozygotes) in the African/African-American population in gnomAD v2.1.1, meeting criteria for BA1 (MAF >0.002). The variant is reported in 1 individual with normal antithrombin levels. SpliceAI and VarSeak predict no impact on splicing and PhyloP gives a conservation score of 0.028 (<0.1). In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Thrombosis Variant Curation Expert Panel for SERPINC1: BA1, BS2_Supporting, BP4, BP7. LINK:https://erepo.genome.network/evrepo/ui/classification/CA1251296/MONDO:0013144/084

Frequency

Genomes: 𝑓 0.48 ( 20306 hom., cov: 33)
Exomes 𝑓: 0.36 ( 100658 hom. )

Consequence

SERPINC1
NM_000488.4 synonymous

Scores

2

Clinical Significance

Benign reviewed by expert panel B:7

Conservation

PhyloP100: 0.121

Publications

38 publications found
Variant links:
Genes affected
SERPINC1 (HGNC:775): (serpin family C member 1) The protein encoded by this gene, antithrombin III, is a plasma protease inhibitor and a member of the serpin superfamily. This protein inhibits thrombin as well as other activated serine proteases of the coagulation system, and it regulates the blood coagulation cascade. The protein includes two functional domains: the heparin binding-domain at the N-terminus of the mature protein, and the reactive site domain at the C-terminus. The inhibitory activity is enhanced by the presence of heparin. Numerous mutations have been identified for this gene, many of which are known to cause antithrombin-III deficiency which constitutes a strong risk factor for thrombosis. A reduction in the serum level of this protein is associated with severe cases of Coronavirus Disease 19 (COVID-19). [provided by RefSeq, Sep 2020]
SERPINC1 Gene-Disease associations (from GenCC):
  • hereditary antithrombin deficiency
    Inheritance: AD, AR, SD Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia, Genomics England PanelApp, Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

BP4
For more information check the summary or visit ClinGen Evidence Repository.
BP7
For more information check the summary or visit ClinGen Evidence Repository.
BS2
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000488.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SERPINC1
NM_000488.4
MANE Select
c.1011A>Gp.Gln337Gln
synonymous
Exon 5 of 7NP_000479.1P01008
SERPINC1
NM_001386302.1
c.1134A>Gp.Gln378Gln
synonymous
Exon 5 of 7NP_001373231.1
SERPINC1
NM_001386303.1
c.1092A>Gp.Gln364Gln
synonymous
Exon 6 of 8NP_001373232.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SERPINC1
ENST00000367698.4
TSL:1 MANE Select
c.1011A>Gp.Gln337Gln
synonymous
Exon 5 of 7ENSP00000356671.3P01008
SERPINC1
ENST00000874328.1
c.1140A>Gp.Gln380Gln
synonymous
Exon 5 of 7ENSP00000544387.1
SERPINC1
ENST00000874324.1
c.1134A>Gp.Gln378Gln
synonymous
Exon 5 of 7ENSP00000544383.1

Frequencies

GnomAD3 genomes
AF:
0.476
AC:
72441
AN:
152116
Hom.:
20255
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.772
Gnomad AMI
AF:
0.323
Gnomad AMR
AF:
0.378
Gnomad ASJ
AF:
0.541
Gnomad EAS
AF:
0.613
Gnomad SAS
AF:
0.385
Gnomad FIN
AF:
0.293
Gnomad MID
AF:
0.535
Gnomad NFE
AF:
0.341
Gnomad OTH
AF:
0.464
GnomAD2 exomes
AF:
0.394
AC:
99142
AN:
251340
AF XY:
0.391
show subpopulations
Gnomad AFR exome
AF:
0.785
Gnomad AMR exome
AF:
0.274
Gnomad ASJ exome
AF:
0.535
Gnomad EAS exome
AF:
0.647
Gnomad FIN exome
AF:
0.296
Gnomad NFE exome
AF:
0.345
Gnomad OTH exome
AF:
0.398
GnomAD4 exome
AF:
0.360
AC:
526270
AN:
1461450
Hom.:
100658
Cov.:
51
AF XY:
0.360
AC XY:
262001
AN XY:
727022
show subpopulations
African (AFR)
AF:
0.792
AC:
26513
AN:
33478
American (AMR)
AF:
0.282
AC:
12624
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.536
AC:
14011
AN:
26134
East Asian (EAS)
AF:
0.577
AC:
22901
AN:
39686
South Asian (SAS)
AF:
0.382
AC:
32981
AN:
86248
European-Finnish (FIN)
AF:
0.300
AC:
15996
AN:
53402
Middle Eastern (MID)
AF:
0.492
AC:
2838
AN:
5766
European-Non Finnish (NFE)
AF:
0.336
AC:
373932
AN:
1111642
Other (OTH)
AF:
0.405
AC:
24474
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
18349
36699
55048
73398
91747
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12306
24612
36918
49224
61530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.477
AC:
72555
AN:
152234
Hom.:
20306
Cov.:
33
AF XY:
0.472
AC XY:
35120
AN XY:
74434
show subpopulations
African (AFR)
AF:
0.773
AC:
32098
AN:
41540
American (AMR)
AF:
0.378
AC:
5779
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.541
AC:
1876
AN:
3468
East Asian (EAS)
AF:
0.613
AC:
3179
AN:
5182
South Asian (SAS)
AF:
0.384
AC:
1855
AN:
4826
European-Finnish (FIN)
AF:
0.293
AC:
3110
AN:
10602
Middle Eastern (MID)
AF:
0.561
AC:
165
AN:
294
European-Non Finnish (NFE)
AF:
0.341
AC:
23219
AN:
68004
Other (OTH)
AF:
0.464
AC:
980
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1698
3396
5094
6792
8490
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
614
1228
1842
2456
3070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.397
Hom.:
21640
Bravo
AF:
0.497
Asia WGS
AF:
0.515
AC:
1793
AN:
3478
EpiCase
AF:
0.367
EpiControl
AF:
0.367

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
Hereditary antithrombin deficiency (4)
-
-
2
not provided (2)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.60
CADD
Benign
9.6
DANN
Benign
0.56
PhyloP100
0.12
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5878; hg19: chr1-173878832; COSMIC: COSV62929416; COSMIC: COSV62929416; API